GoodRx Holdings, Inc. — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GoodRx Holdings, Inc. (GDRX)
CIK: 0001809519
Period of Report: 2021-01-01

Reporting Person: Slutsky Andrew (President, Consumer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-01	Class A Common Stock	M	62500	—	Acquired	3702328	Direct
2021-01-01	Class A Common Stock	F	27482	$40.34	Disposed	3674846	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-01	Restricted Stock Units	$	M	62500	Disposed		Class A Common Stock (62500)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

F2: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date.